These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 10606622)

  • 1. A transgenic rabbit model for human hypertrophic cardiomyopathy.
    Marian AJ; Wu Y; Lim DS; McCluggage M; Youker K; Yu QT; Brugada R; DeMayo F; Quinones M; Roberts R
    J Clin Invest; 1999 Dec; 104(12):1683-92. PubMed ID: 10606622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased left ventricular ejection fraction in transgenic mice expressing mutant cardiac troponin T-Q(92), responsible for human hypertrophic cardiomyopathy.
    Lim DS; Oberst L; McCluggage M; Youker K; Lacy J; DeMayo F; Entman ML; Roberts R; Michael LH; Marian AJ
    J Mol Cell Cardiol; 2000 Mar; 32(3):365-74. PubMed ID: 10731436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of expression of cardiac phenotypes over a 4-year period in the beta-myosin heavy chain-Q403 transgenic rabbit model of human hypertrophic cardiomyopathy.
    Nagueh SF; Chen S; Patel R; Tsybouleva N; Lutucuta S; Kopelen HA; Zoghbi WA; Quiñones MA; Roberts R; Marian AJ
    J Mol Cell Cardiol; 2004 May; 36(5):663-73. PubMed ID: 15135661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue Doppler imaging consistently detects myocardial contraction and relaxation abnormalities, irrespective of cardiac hypertrophy, in a transgenic rabbit model of human hypertrophic cardiomyopathy.
    Nagueh SF; Kopelen HA; Lim DS; Zoghbi WA; Quiñones MA; Roberts R; Marian AJ
    Circulation; 2000 Sep; 102(12):1346-50. PubMed ID: 10993850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy.
    Patel R; Nagueh SF; Tsybouleva N; Abdellatif M; Lutucuta S; Kopelen HA; Quinones MA; Zoghbi WA; Entman ML; Roberts R; Marian AJ
    Circulation; 2001 Jul; 104(3):317-24. PubMed ID: 11457751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo short-term expression of a hypertrophic cardiomyopathy mutation in adult rabbit myocardium: myofibrillar incorporation without early disarray.
    Yu Q; Zhao G; Marian AJ
    Proc Assoc Am Physicians; 1999; 111(1):45-56. PubMed ID: 9893156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-Myosin heavy chain variant Val606Met causes very mild hypertrophic cardiomyopathy in mice, but exacerbates HCM phenotypes in mice carrying other HCM mutations.
    Blankenburg R; Hackert K; Wurster S; Deenen R; Seidman JG; Seidman CE; Lohse MJ; Schmitt JP
    Circ Res; 2014 Jul; 115(2):227-37. PubMed ID: 24829265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resolution of established cardiac hypertrophy and fibrosis and prevention of systolic dysfunction in a transgenic rabbit model of human cardiomyopathy through thiol-sensitive mechanisms.
    Lombardi R; Rodriguez G; Chen SN; Ripplinger CM; Li W; Chen J; Willerson JT; Betocchi S; Wickline SA; Efimov IR; Marian AJ
    Circulation; 2009 Mar; 119(10):1398-407. PubMed ID: 19255346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of cardiac hypertrophy by atorvastatin in a transgenic rabbit model of human hypertrophic cardiomyopathy.
    Senthil V; Chen SN; Tsybouleva N; Halder T; Nagueh SF; Willerson JT; Roberts R; Marian AJ
    Circ Res; 2005 Aug; 97(3):285-92. PubMed ID: 16020756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of a mutation causing hypertrophic cardiomyopathy disrupts sarcomere assembly in adult feline cardiac myocytes.
    Marian AJ; Yu QT; Mann DL; Graham FL; Roberts R
    Circ Res; 1995 Jul; 77(1):98-106. PubMed ID: 7788887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular genetics and pathogenesis of hypertrophic cardiomyopathy.
    Marian AJ; Salek L; Lutucuta S
    Minerva Med; 2001 Dec; 92(6):435-51. PubMed ID: 11740432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertrophic cardiomyopathy R403Q mutation in rabbit β-myosin reduces contractile function at the molecular and myofibrillar levels.
    Lowey S; Bretton V; Joel PB; Trybus KM; Gulick J; Robbins J; Kalganov A; Cornachione AS; Rassier DE
    Proc Natl Acad Sci U S A; 2018 Oct; 115(44):11238-11243. PubMed ID: 30322937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in mitochondrial function in a mouse model of hypertrophic cardiomyopathy.
    Lucas DT; Aryal P; Szweda LI; Koch WJ; Leinwand LA
    Am J Physiol Heart Circ Physiol; 2003 Feb; 284(2):H575-83. PubMed ID: 12414446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exercise can prevent and reverse the severity of hypertrophic cardiomyopathy.
    Konhilas JP; Watson PA; Maass A; Boucek DM; Horn T; Stauffer BL; Luckey SW; Rosenberg P; Leinwand LA
    Circ Res; 2006 Mar; 98(4):540-8. PubMed ID: 16439687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of beta-myosin heavy chain mutations is reflective of their hypertrophic expressivity in patients with hypertrophic cardiomyopathy.
    Abchee A; Marian AJ
    J Investig Med; 1997 Apr; 45(4):191-6. PubMed ID: 9154300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irreversible triggers for hypertrophic cardiomyopathy are established in the early postnatal period.
    Cannon L; Yu ZY; Marciniec T; Waardenberg AJ; Iismaa SE; Nikolova-Krstevski V; Neist E; Ohanian M; Qiu MR; Rainer S; Harvey RP; Feneley MP; Graham RM; Fatkin D
    J Am Coll Cardiol; 2015 Feb; 65(6):560-9. PubMed ID: 25677315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking cardiac growth in hypertrophic cardiomyopathy induces cardiac dysfunction and decreased survival only in males.
    Luckey SW; Mansoori J; Fair K; Antos CL; Olson EN; Leinwand LA
    Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H838-45. PubMed ID: 17012357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mice expressing mutant myosin heavy chains are a model for familial hypertrophic cardiomyopathy.
    Vikstrom KL; Factor SM; Leinwand LA
    Mol Med; 1996 Sep; 2(5):556-67. PubMed ID: 8898372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy.
    Lim DS; Lutucuta S; Bachireddy P; Youker K; Evans A; Entman M; Roberts R; Marian AJ
    Circulation; 2001 Feb; 103(6):789-91. PubMed ID: 11171784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial hypertrophic cardiomyopathy: a paradigm of the cardiac hypertrophic response to injury.
    Marian AJ; Roberts R
    Ann Med; 1998 Aug; 30 Suppl 1():24-32. PubMed ID: 9800880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.